Earnings Per Share, Basic in USD/shares of Ambrx Biopharma Cayman, Inc. from 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from 2021 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Earnings Per Share, Basic for the quarter ending 30 Jun 2023 was 0 USD/shares, a 54.5% increase year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Earnings Per Share, Basic for 2022 was 0 USD/shares, a 39.6% increase from 2021.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $0 +$0.06 +54.5% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $0 +$0.03 +37.5% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q2 2022 $0 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023

Ambrx Biopharma Cayman, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 +$0.19 +39.6% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 $0 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.